Expression of cytochrome P450 and MDR1 in patients with proctitis

References

• Nebert, D. W. and Russell, D. W. (2002) Clinical importance of the cytochromes P450 Lancet 360: 1155–1162
   Google Scholar
• Ueda, K., Cornwell, M. M., Gottesman, M. M., Pastan, I., Roninson, I. B., Ling, V. and Riordan, J. R. (1986) The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein Bio-chem Biophys Res Commun 141: 956–962
   PubMed Web of Science ®Google Scholar
• Willingham, M. C., Cornwell, M. M., Cardarelli, C. 0., Gottesman, M. M. and Pastan, I. (1986) Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs Cancer Res 46: 5941–5946
   Google Scholar
• Wu, C. Y., Benet, L. Z., Hebert, M. F., Gupta, S. K., Rowland, M., Gomez, D. Y. and Wacher, V. J. (1995) Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine Chin Pharmacol Ther 58: 492–497
   PubMed Web of Science ®Google Scholar
• Klotz, U., Hoensch, H., Schatz, T., Beaune, P., Zanger, U., Bode, J. C. and Fritz, P. (1998) Ex-pression of intestinal drug-metabolising enzymes in patients with chronic inflammatory bowel disease. Current Theapeutic Research 556–563
   Google Scholar
• McKinnon, R. A., Burgess, W. M., Hall, P. M., Roberts-Thomson, S. J., Gonzalez, F. J. and Mc-Manus, M. E. (1995) Characterisation of CYP3A gene subfamily expression in human gastroin-testinal tissues Gut 36: 259–267
   Google Scholar
• Kolars, J. C., Lown, K. S., Schmiedlin-Ren, P., Ghosh, M., Fang, C., Wrighton, S. A., Merion, R. M. and Watkins, P. B. (1994) CYP3A gene expression in human gut epithelium Pharmacogenet-ics 4: 247–259
   Google Scholar
• Thorn, M., Finnstrom, N., Lundgren, S., Rane, A. and Loof, L. (2005) Cytochromes P450 and MDR1 expression gradients along the human gastrointestinal tract. Brit. J Clinical Pharm 60: 54–60
   PubMed Web of Science ®Google Scholar
• Xu, C. T., Meng, S. Y. and Pan, B. R. (2004) Drug therapy for ulcerative colitis World J Gastro-enterol 10: 2311–2317
   PubMed Web of Science ®Google Scholar
• Griffin, M. G. and Miner, P. B. (1996) Review article: refractory distal colitis -- explanations and options Aliment Pharmacol Ther 10: 39–48
   PubMedGoogle Scholar
• Farrell, R. J., Murphy, A., Long, A., Donnelly, S., Cherikuri, A., O'Toole, D., Mahmud, N., Keel-ing, P. W., Weir, D. G. and Kelleher, D. (2000) High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy Gastroenterology 118: 279–288
   Google Scholar
• Ingelman-Sundberg, M., Oscarson, M. and McLellan, R. A. (1999) Polymorphic human cyto-chrome P450 enzymes: an opportunity for individualized drug treatment Trends Pharmacol Sci 20: 342–349
   PubMed Web of Science ®Google Scholar
• Brant, S. R., Panhuysen, C. I., Nicolae, D., Reddy, D. M., Bonen, D. K., Karaliukas, R., Zhang, L., Swanson, E., Dana, L. W., Moran, T., Ravenhill, G., Duerr, R. H., Achkar, J. P., Karban, A. S. and Cho, J. H. (2003) MDR1 A1a893 polymorphism is associated with inflammatory bowel disease Am J Hum Genet 73: 1282–1292
   Google Scholar
• Renton, K. W. (2001) Alteration of drug biotransformation and elimination during infection and inflammation Pharmacol Ther 92: 147–163
   Google Scholar
• Morgan, E. T. (2001) Regulation of cytochrome p450 by inflammatory mediators: why and how? Drug Metab Dispos 29: 207–212
   PubMed Web of Science ®Google Scholar
• Bertilsson, P. M., Olsson, P. and Magnusson, K. E. (2001) Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells J Pharm Sci 90: 638–646
   Google Scholar
• Panwala, C. M., Jones, J. C. and Viney, J. L. (1998) A novel model of inflammatory bowel dis-ease: mice deficient for the multiple drug resistance gene, mdrl a, spontaneously develop colitis J Immunol 161: 5733–5744
   Google Scholar
• Ho, G. T., Moodie, F. M. and Satsangi, J. (2003) Multidrug resistance 1 gene (P-glycoprotein 170): an important determinant in gastrointestinal disease? Gut 52: 759–766
   Google Scholar
• Schwab, M., Schaeffeler, E., Marx, C., Fromm, M. F., Kaskas, B., Metzler, J., Stange, E., Her-farth, H., Schoelmerich, J., Gregor, M., Walker, S., Cascorbi, I., Roots, I., Brinkmann, U., Zanger, U. M. and Eichelbaum, M. (2003) Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis Gastroenterology 124: 26–33
   Google Scholar
• Glas, J., Torok, H. P., Schiemann, U. and Folwacrny, C. (2004) MDR1 gene polymorphism in ulcerative colitis Gastroenterology 126: 367
   Google Scholar
• Gazouli, M., Zacharatos, P., Gorgoulis, V, Mantzaris, G., Papalambros, E. and Ikonomopoulos, J. (2004) The C3435T MDR1 gene polymorphism is not associated with susceptibility for ulcera-tive colitis in Greek population Gastroenterology 126: 367–369
   Google Scholar
• Croucher, P. J., Mascheretti, S., Foelsch, U. R., Hampe, J. and Schreiber, S. (2003) Lack of as-sociation between the C3435T MDR1 gene polymorphism and inflammatory bowel disease in two independent Northern European populations Gastroenterology 125: 1919–1920; author reply 1920–1911
   Google Scholar
• Bowen, W. P., Carey, J. E., Miah, A., McMurray, H. F., Munday, P. W., James, R. S., Coleman, R. A. and Brown, A. M. (2000) Measurement of cytochrome P450 gene induction in human hepa-tocytes using quantitative real-time reverse transcriptase-polymerase chain reaction Drug Metab Dispos 28: 781–788
   Google Scholar
• Finnstrom, N., Thorn, M., Loof, L. and Rane, A. (2001) Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease Eur J Chin Phar-macol 57: 403–409
   Google Scholar
• Thorn, M., Lundgren, S., Herlenius, G., Ericzon, B. G., Loof, L. and Rane, A. (2004) Gene ex-pression of cytochromes P(450) in liver transplants over time Eur J Chin Pharmacol 60: 413–420
   Google Scholar
• George, J., Liddle, C., Murray, M., Byth, K. and Farrell, G. C. (1995) Pre-translational regula-tion of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis Biochem Pharmacol 49: 873–881
   Google Scholar
• Sumida, A., Kinoshita, K., Fukuda, T., Matsuda, H., Yamamoto, I., Inaba, T. and Azuma, J. (1999) Relationship between mRNA levels quantified by reverse transcription-competitive PCR and metabolic activity of CYP3A4 and CYP2E1 in human liver Biochem Biophys Res Commun 262: 499–503
   Google Scholar
• Rodriguez-Antona, C., Donato, M. T., Pareja, E., Gomez-Lechon, M. J. and Castell, J. V. (2001) Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity Arch Biochem Biophys 393: 308–315
   Google Scholar
• Kuehl, P., Zhang, J., Lin, Y, Lamba, J., Assem, M., Schuetz, J., Watkins, P. B., Daly, A., Wrighton, S. A., Hall, S. D., Maurel, P., Relling, M., Brimer, C., Yasuda, K., Venkataramanan, R., Strom, S., Thummel, K., Boguski, M. S. and Schuetz, E. (2001) Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression Nat Genet 27: 383–391
   Google Scholar
• Lown, K. S., Kolars, J. C., Thummel, K. E., Barnett, J. L., Kunze, K. L., Wrighton, S. A. and Watkins, P. B. (1994) Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test Drug Metab Dispos 22: 947–955
   PubMed Web of Science ®Google Scholar
• Stephens, R. H., Tanianis-Hughes, J., Higgs, N. B., Humphrey, M. and Warhurst, G. (2002) Re-gion-dependent modulation of intestinal permeability by drug efflux transporters: in vitro studies in mdrla(-/-) mouse intestine J Pharmacol Exp Ther 303: 1095–1101
   Google Scholar
• Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M. and Pastan, I. (1987) Expression of a multidrug-resistance gene in human tumors and tissues Proc Natl Acad Sci U S A 84: 265–269
   PubMed Web of Science ®Google Scholar
• Piquette-Miller, M., Pak, A., Kiln, H., Anari, R. and Shahzamani, A. (1998) Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation Pharm Res 15: 706–711
   Google Scholar
• McRae, M. P., Brouwer, K. L. and Kashuba, A. D. (2003) Cytokine regulation of P-glycoprotein Drug Metab Rev 35: 19–33
   PubMed Web of Science ®Google Scholar
• Saclarides, T. J., Jakate, S. M., Coon, J. S., Bhattacharyya, A. K., Dominguez, J. M., Szeluga, D. J. and Weinstein, R. S. (1992) Variable expression of P-glycoprotein in normal, inflamed, and dysplastic areas in ulcerative colitis Dis Colon Rectum 35: 747–752
   PubMed Web of Science ®Google Scholar
• Goto, M., Masuda, S., Saito, H. and Inui, K. (2003) Decreased expression of P-glycoprotein dur-ing differentiation in the human intestinal cell line Caco-2 Biochem Pharmacol 66: 163–170
   Google Scholar